文献速递其他结缔组织病

系统性硬化症中的结肠传输缓慢:危险因素与临床表型的客观评估

Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical Phenotype.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-09-13

该前瞻性研究纳入100例有胃肠道症状的系统性硬化症(SSc)患者,采用闪烁显像全肠道传输研究评估结肠传输缓慢。48%患者存在结肠传输缓慢,多变量分析显示毛细血管扩张和限制性肺病较轻与结肠传输缓慢独立相关。

要点

  • 48%有胃肠道症状的SSc患者存在结肠传输缓慢。
  • 毛细血管扩张与结肠传输缓慢独立正相关(OR 3.97)。
  • 限制性肺病较轻与结肠传输缓慢独立负相关(OR 0.28)。

核心结论

  • SSc患者中结肠传输缓慢与特定临床特征相关,可能有助于风险分层和疾病机制研究。

研究设计与样本

  • 前瞻性队列研究,纳入100例有胃肠道症状的SSc患者,完成闪烁显像全肠道传输研究。

主要发现

  • 100例患者中48例(48%)存在结肠传输缓慢。
  • 单变量分析中,结肠传输缓慢与女性(OR 12.61 [95%CI 1.56-101.90])、毛细血管扩张(OR 4.00 [95%CI 1.32-12.10])、抗着丝点抗体(OR 3.25 [95%CI 1.25-8.44])、既往或当前吸烟(OR 2.56 [95%CI 1.06-6.21])及Medsger胃肠道严重度评分≥3(OR 3.94 [95%CI 1.16-13.36])正相关,与肺功能检查显著限制性负相关(OR 0.23 [95%CI 0.09-0.63])。
  • 多变量模型中,毛细血管扩张(OR 3.97 [95%CI 1.20-13.20])和肺功能限制性较轻(OR 0.28 [95%CI 0.09-0.86])与结肠传输缓慢的关联仍显著,吸烟呈趋势(OR 2.16 [95%CI 0.82-5.75])。
  • 结肠传输缓慢与其他胃肠道区域传输延迟无显著关联。

临床怎么用

  • 对SSc患者,尤其女性、有毛细血管扩张、抗着丝点抗体阳性、吸烟史或Medsger胃肠道评分≥3者,应警惕结肠传输缓慢。
  • 肺功能限制性较轻的SSc患者也可能存在结肠传输缓慢,需结合胃肠道症状评估。

局限性

  • 样本量较小(100例),单中心前瞻性研究,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Up to 50% of patients with systemic sclerosis (SSc) experience slow colonic transit, which may be associated with severe outcomes. Our objective, therefore, was to identify specific clinical features associated with slow colonic transit in SSc. METHODS: SSc patients with gastrointestinal symptoms were prospectively enrolled and completed a scintigraphy-based whole gut transit study. Clinical features were compared between patients with and without slow colonic transit in univariate and multivariable logistic regression analyses. RESULTS: Forty-eight of 100 patients (48%) in our cohort had slow colonic transit. In the univariate analyses, slow colonic transit was positively associated with female sex (odds ratio [OR] 12.61 [95% confidence interval (95% CI) 1.56-101.90]), telangiectasia (OR 4.00 [95% CI 1.32-12.10]), anticentromere antibodies (OR 3.25 [95% CI 1.25-8.44]), prior or current smoking (OR 2.56 [95% CI 1.06-6.21]), and a Medsger gastrointestinal severity score of ≥3 (OR 3.94 [95% CI 1.16-13.36]). Patients were less likely to have significant restriction on pulmonary function tests (OR 0.23 [95% CI 0.09-0.63]). In our multivariable model, the association between slow colonic transit and telangiectasia (OR 3.97 [95% CI 1.20-13.20]) and less restrictive lung disease on pulmonary function tests (OR 0.28 [95% CI 0.09-0.86]) remained statistically significant, though a trend with smoking remained (OR 2.16 [95% CI 0.82-5.75]). Interestingly, there were no significant associations between slow colonic transit and delayed transit in other regions of the gastrointestinal tract. CONCLUSION: Distinct clinical features are associated with slow colonic transit in SSc. Such features may provide insight in risk stratification and the study of disease mechanism in more homogeneous subgroups.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Cheah JX, Perin J, Volkmann ER, et al. Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical Phenotype. Arthritis Care Res (Hoboken). 2022. PMID: 34369086. doi:10.1002/acr.24767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。